Health & Science
Eli Lilly's Retatrutide Yields 28% Weight Loss in Trial
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.
—5 min read
Tag
1 article
Eli Lilly's retatrutide led to 28.3% weight loss in a Phase 3 trial, approaching bariatric surgery results. But high side effect rates raise questions.